Suven Life to present its portfolio at IBRO 2007 World Congress of Neuroscience at Melbourne

Suven Life Sciences Ltd has announced that several data presentations from Suven's portfolio of investigational neuroscience compounds will be presented at International Brain Research Organisation (IBRO) 2007 World Congress of Neuroscience to be held at Melbourne, Australia during July 12-17, 2007.

Scientists from Suven Discovery Research will be presenting new data for 4 promising areas of neuroscience viz, Alzheimer's, Schizophrenia, Parkinson and Obesity diseases. These areas present significant unmet Medical need for which current treatment options are insufficient. The Company has a number of programs in each of these areas, focusing on novei approaches that may lead to the development of new therapies for patients.

The Company is presenting the data on their leading preclinical candidates SUVN-502 and SUVN-507 at IBRO 2007 world congress of Neuroscience.

The Company is committed to neuroscience research and for development of new treatments for neurological disorders. Suven's discovery research focuses on Central Nervous System (CNS) disorders through novel mechanisms using small-molecule medicinal chemistry approaches. Suven's CNS drug discovery scientists at Hyderabad, India are pursuing innovative ways to develop treatments for a variety of CNS disorders like Alzheimer's, Schizophrenia, Depression, Cognitive disorders and Neurodegeneration.

Source : Equity Bulls

Keywords